Weekly low-dose methotrexate therapy for cutaneous sarcoidosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2061444.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Three patients with severe, treatment-resistant cutaneous sarcoidosis were treated with low-dose oral methotrexate on a weekly basis. Facial granulomas and ulcerations responded best. A response was apparent after several weeks of treatment, but 6 to 9 months were required to reach maximal effect.
Medical subject headings
- Methotrexate
- Sarcoidosis
- Skin Diseases